Structure Therapeutics Accounts Payable

Structure Therapeutics (GPCR) currently reports a accounts payable of $11M as of June 2026. That compares with $9M in the prior-year period — up 23.8% year over year. Use the charts on this page to explore Structure Therapeutics's accounts payable history and peer comparisons.

Structure Therapeutics's accounts payable increased from $9M to $11M — a 23.8% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Structure Therapeutics reported $11M in accounts payable as of June 2026. That compares with $9M in the prior-year period — up 23.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Structure Therapeutics, and consider following GPCR for alerts when major investors trade the stock.